Respiratorius AB (publ) (NGM:RESP)

Respiratorius AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Apr 30, 2022	Dec 31, 2021
Cost of Revenue	-	0.76	10.66	-	16.78
Gross Profit	-	-0.76	-10.66	-	-16.78
Selling, General & Admin	4.62	5.13	11.07	10.19	8.07
Research & Development	-0.51	-	-	-1.85	-18.33
Other Operating Expenses	-	-1.35	-11.18	-0.4	-
Operating Expenses	7.51	7.07	2.21	12.69	-7.23
Operating Income	-7.51	-7.83	-12.87	-12.69	-9.55
Interest Expense	-	-0	-0	-0	-0.09
Interest & Investment Income	-	0.01	0	-	-
Other Non Operating Income (Expenses)	-0	-	-	-	-
EBT Excluding Unusual Items	-7.51	-7.83	-12.87	-12.69	-9.64
Gain (Loss) on Sale of Investments	-0.06	-	-	-	-
Pretax Income	-7.57	-7.83	-12.87	-12.69	-9.64
Net Income	-7.57	-7.83	-12.87	-12.69	-9.64
Net Income to Common	-7.57	-7.83	-12.87	-12.69	-9.64
Shares Outstanding (Basic)	4	3	-	-	2
Shares Outstanding (Diluted)	4	3	-	-	2
Shares Change (YoY)	37.21%	-	-	-	29.08%
EPS (Basic)	-1.89	-2.68	-	-	-4.00
EPS (Diluted)	-1.89	-2.68	-	-	-4.00
EBITDA	-4.11	-7.48	-12.31	-9.7	-8.36
D&A For EBITDA	3.39	0.35	0.56	2.99	1.19
EBIT	-7.51	-7.83	-12.87	-12.69	-9.55
Revenue as Reported	-	-	-	0.4	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.